Pyruvate kinase isoenzyme M2 is not of diagnostic relevance as a marker for oral cancer

Bena-Boupda, 2003, Value of tumor M2-PK in thyroid carcinoma: a pilot study, Anticancer Res, 23, 5237 Brinck, 1994, L- and M2-pyruvate kinase expression in renal cell carcinomas and their metastases, Virchows Arch, 424, 177, 10.1007/BF00193498 Eigenbrodt, 1998, Pyruvate kinase and the interaction of amino acid and carbohydrate metabolism in solid tumors, Anticancer Res, 18, 3267 Ewald, 2005, Pyruvatkinase M2 (Tumor M2-PK) im Stuhl als Screeningparameter für kolorektale Neoplasien. Eine Übersicht über bisher publizierte Daten, Z Gastroenterol, 43, 1313, 10.1055/s-2005-858657 Field, 1995, Oral mucosal screening as an integral part of routine dental care, Br Dent J, 179, 262, 10.1038/sj.bdj.4808894 Hardt, 2000, Tumor M2 pyruvate kinase: a promising tumor marker in the diagnosis of gastro-intestinal cancer, Anticancer Res, 20, 4965 Hardt, 2004, Faecal tumor M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer, Br J Cancer, 91, 980, 10.1038/sj.bjc.6602033 Hegele, 2003, Pyruvate kinase type M2 in urological malignancies, Urol Int, 70, 55, 10.1159/000067707 Howaldt, 2000, Ergebnisse aus dem DÖSAK-Tumorregister, Mund Kiefer Gesichtschir, 4, S216, 10.1007/PL00014543 Kaura, 2004, Evaluation of the pyruvate kinase isoenzyme tumor (Tu M2-PK) as a tumor marker for cervical carcinoma, J Obstet Gynaecol Res, 30, 193, 10.1111/j.1447-0756.2004.00187.x Koss, 2004, The metabolic marker tumour pyruvate kinase type M2 (tumour M2-PK) shows increased expression along the metaplastic–dysplasia–adenocarcinoma sequence in Barrett's oesophagus, J Clin Pathol, 57, 1156, 10.1136/jcp.2004.018150 Lueftner, 2000, Tumor type M2 pyruvate kinase expression in advanced breast cancer, Anticancer Res, 20, 5077 Mazurek, 2000, Tumor M2-PK and glutaminolytic enzymes in the metabolic shift of tumor cells, Anticancer Res, 20, 5151 Mazurek, 2005, Pyruvate kinase type M2 and its role in tumor growth and spreading, Semin Cancer Biol, 15, 300, 10.1016/j.semcancer.2005.04.009 McDowell, 2004, Plasma concentrations of tumour dimeric pyruvate kinase are increased in patients with chronic cardiac failure, Ann Clin Biochem, 41, 491, 10.1258/0004563042466712 Murphy, 2006, Tumor M2 pyruvate kinase as a stool marker for colorectal cancer: stability at room temperature and implications for application in the screening setting, Clin Chem, 52, 781, 10.1373/clinchem.2005.064212 Oremek, 1999, The pyruvate kinase isoenzyme tumor Me (Tu M2-PK) as a tumor marker for renal carcinoma, Anticancer Res, 19, 2599 Oremek, 2000, Value of tumor M2 (Tu M2-PK) in patients with renal carcinoma, Anticancer Res, 20, 5095 Oremek, 2003, Pre-analytical problems in the measurement of tumor type pyruvate kinase (tumor M2-PK), Anticancer Res, 23, 1127 Oremek, 2003, Tumor M2-PK levels in haematological malignancies, Anticancer Res, 23, 1135 Oremek, 2003, Tumor marker pyruvate kinase type tumor M2 in patients suffering from diabetic nephropathy, Anticancer Res, 23, 1155 Perkins, 2003, Serum tumor markers, Am Fam Physician, 15, 1075 Rijksen, 1988, Subunit-specific phosphorylation of pyruvate kinase in medullary thyroid carcinomas of the rat, FEBS Lett, 233, 69, 10.1016/0014-5793(88)81357-7 Roigas, 2003, Tumor type M2 pyruvate kinase expression in metastatic renal cell carcinoma, Urol Res, 31, 358, 10.1007/s00240-003-0331-4 Schneider, 2003, Comparison of tumor M2-pyruvate kinase (tumor M2-PK), carcinoembryonic antigen (CEA), carbohydrate antigens CA 19-9 and CA 72-4 in the diagnosis of gastrointestinal cancer, Anticancer Res, 23, 5089 Schneider, 2000, Comparison of the tumor markers tumor M2-PK, CEA, CYRFA 21-1, NSE and SCC in the diagnosis of lung cancer, Anticancer Res, 20, 5053 Schneider, 2003, Tumor M2-pyruvate kinase in the follow-up of inoperable lung cancer patients: a pilot study, Cancer Lett, 193, 91, 10.1016/S0304-3835(02)00720-6 Schulze, 2000, The tumor marker tumor M2-PK: an application in the diagnosis of gastrointestinal cancer, Anticancer Res, 20, 4961 2002 Staib, 2006, Plasma levels of tumor M2-pyruvate kinase should not be used as a tumor marker for hematological malignancies and solid tumors, Clin Chem Lab Med, 44, 28, 10.1515/CCLM.2006.006 Ugurel, 2005, Tumor type M2 pyruvate kinase (TuM2-PK) as a novel plasma tumor marker in melanoma, Int J Cancer, 117, 825, 10.1002/ijc.21073 Varga, 2002, Determination of pyruvate kinase type tumor M2 in human renal cell carcinoma: a suitable tumor marker?, Urol Res, 30, 122, 10.1007/s00240-002-0246-5 Ventrucci, 2004, Tumor M2-pyruvate kinase, a new metabolic marker for pancreatic cancer, Dig Dis Sci, 49, 1149, 10.1023/B:DDAS.0000037803.32013.aa Vogel, 2005, Vergleich verschiedener Stuhltests zur Detektion von Neoplasien des Kolon, Dtsch Med Wochenschr, 130, 872, 10.1055/s-2005-865100 Zhang, 2004, Tumor type M2 pyruvate kinase expression in gastric cancer, colorectal cancer and controls, World J Gastroenterol, 10, 1643, 10.3748/wjg.v10.i11.1643